News

The product is indicated for the treatment of community-acquired pneumonia and pelvic inflammatory disease, when caused by susceptible microorganisms. Sales of this product exceeded $69 million in 2004

The proposed merger is subject to approval of the stockholders of both ActivBiotics and Metaphore and is expected to close by the end of December or early January.

The phase II clinical trial is designed to determine the efficacy of four dose levels of NG2-73 compared to placebo in reducing the time it takes to fall

Maxygen established the alliance with Roche in May 2003 in which Roche licensed worldwide commercialization rights to specific novel interferon alpha product candidates developed by Maxygen for hepatitis

The written agreement specifies the terms and conditions under which Nuvelo will conduct and analyze the pivotal phase III trial in support of a regulatory submission. The trial,

Treatment with a combination of Zadaxin and pegylated interferon alpha did not demonstrate a statistically significant benefit compared to treatment with pegylated interferon alone in sustained viral response

The company said that it expects to submit an investigational new drug application for an RNAi therapeutic for the treatment of pandemic flu as early as the end

The technology includes specific Fc (antibody constant region) variants that complement Xencor’s proprietary suite of XmAb engineered Fc domains, which are designed to enhance the therapeutic properties of

Merck has gained access to MorphoSys’ proprietary technologies, HuCal gold and AutoCal, for use in its drug discovery programs, and will be able to develop HuCal-derived therapeutic antibodies